MacroGenics (MGNX)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	179.63 mm	179.63 mm	179.63 mm	179.63 mm	179.63 mm	179.63 mm
Cash burn (monthly)	(no burn)	(no burn)	(no burn)	8.92 mm	(no burn)	4.83 mm
Cash used (since last report)	n/a	n/a	n/a	45.35 mm	n/a	24.56 mm
Cash remaining	n/a	n/a	n/a	134.28 mm	n/a	155.06 mm
Runway (months of cash)	n/a	n/a	n/a	15.0	n/a	32.1

Beta Read what these cash burn values mean

Financial data from MacroGenics earnings reports.

Institutional ownership, Q4 2024

MGNX institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	130	126	+3.2%
Opened positions	24	16	+50.0%
Closed positions	20	36	-44.4%
Increased positions	41	38	+7.9%
Reduced positions	36	45	-20.0%

13F shares	Current	Prev Q	Change
Total value	174.84 bn	178.77 bn	-2.2%
Total shares	68.04 mm	66.21 mm	+2.8%
Total puts	196.70 k	238.30 k	-17.5%
Total calls	28.30 k	214.80 k	-86.8%
Total put/call ratio	7.0	1.1	+526.5%

Largest owners	Shares	Value	Change
BBBOF BB Biotech	9.93 mm	$29.89 mm	0.0%
BLVGF Bellevue	9.93 mm	$32.27 bn	0.0%
Armistice Capital	6.28 mm	$20.40 bn	+0.3%
BlackRock	5.06 mm	$16.44 bn	-6.4%
Vanguard	4.32 mm	$14.03 bn	-0.9%
Wasatch Advisors	3.49 mm	$11.34 bn	+37.6%
Frazier Life Sciences Management	3.18 mm	$10.32 bn	+5.5%
Millennium Management	2.86 mm	$9.31 bn	-19.0%
Frazier Life Sciences Public Fund	1.55 mm	$5.21 mm	NEW
STT State Street	1.46 mm	$4.75 bn	+2.5%

Largest transactions	Shares	Bought/sold	Change
Frazier Life Sciences Public Fund	1.55 mm	+1.55 mm	NEW
Wasatch Advisors	3.49 mm	+952.69 k	+37.6%
Schonfeld Strategic Advisors	857.51 k	+857.51 k	NEW
MS Morgan Stanley	1.10 mm	+784.56 k	+245.3%
T. Rowe Price	485.99 k	-768.25 k	-61.3%
Millennium Management	2.86 mm	-671.18 k	-19.0%
Vestal Point Capital	280.00 k	-550.00 k	-66.3%
BlackRock	5.06 mm	-348.30 k	-6.4%
JPM JPMorgan Chase & Co.	546.81 k	+221.91 k	+68.3%
Renaissance Technologies	538.52 k	+220.10 k	+69.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MGNX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Feb 25	Eck Stephen L.	Common Stock	Payment of exercise	Dispose F	No	No	2.56	4,942	12.65 k	29,377
15 Feb 25	Eck Stephen L.	Common Stock	Option exercise	Acquire M	No	No	0	16,665	0.00	34,319
15 Feb 25	Eck Stephen L.	RSU Common Stock	Option exercise	Dispose M	No	No	0	16,665	0.00	16,665
15 Feb 25	Spitznagel Thomas	Common Stock	Payment of exercise	Dispose F	No	No	2.56	5,520	14.13 k	21,402
15 Feb 25	Spitznagel Thomas	Common Stock	Option exercise	Acquire M	No	No	0	13,332	0.00	26,922
15 Feb 25	Spitznagel Thomas	RSU Common Stock	Option exercise	Dispose M	No	No	0	13,332	0.00	13,332
15 Feb 25	Peters Jeffrey Stuart	Common Stock	Payment of exercise	Dispose F	No	No	2.56	5,147	13.18 k	13,711
15 Feb 25	Peters Jeffrey Stuart	Common Stock	Option exercise	Acquire M	No	No	0	13,332	0.00	18,858
15 Feb 25	Peters Jeffrey Stuart	RSU Common Stock	Option exercise	Dispose M	No	No	0	13,332	0.00	13,332
15 Feb 25	Koenig Scott	Common Stock	Option exercise	Acquire M	No	No	0	42,329	0.00	777,415

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

MacroGenics to Participate in Upcoming Investor Conferences

27 Feb 25

ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics

Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

6 Feb 25

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of MacroGenics, Inc.

MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating Macrogenics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

10 Dec 24

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Macrogenics, Inc. (NASDAQ:MGNX) on behalf of